- Methylergometrine drug
- Methylergometrine side effects
- Methylergometrine methylergometrine dosage
- Methylergometrine mg
- Methylergometrine tablet
What special precautions should I follow?
Before taking methylergonovine,
- tell your doctor and pharmacist if you are allergic to methylergonovine, other ergot alkaloids (Cafergot, Ergostat, Bellergal), or any other drugs.
- tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially other ergot alkaloids and vitamins.
- tell your doctor if you have or have ever had high blood pressure or blood vessel, heart, kidney, or liver disease.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking methylergonovine, call your doctor.
What side effects can this medication cause?
Methylergonovine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- upset stomach
- bad taste in mouth
If you experience any of the following symptoms, call your doctor immediately:
- chest pain
- fast heartbeat
- difficulty breathing
- ringing in the ears
- leg cramps
- skin rash
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take:
- DELAVIRDINE MESYLATE/METHYLERGONOVINE
- INDINAVIR SULFATE/METHYLERGONOVINE
- METHYLERGONOVINE/MIBEFRADIL DIHYDROCHLORIDE
- METHYLERGONOVINE/NELFINAVIR MESYLATE
This is not a complete list of Methylergometrinedrug interactions. Ask your doctor or pharmacist for more information.
Methylergometrine and Pregnancy
Tell your doctor if you are pregnant or plan to become pregnant.
The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.
Methylergonovine falls into category C:
In animal studies, pregnant animals were given this medication and had some babies born with problems. No well-controlled studies have been done in humans, though. Therefore, this medication may be used if the potential benefits to the mother outweigh the potential risks to the unborn child.
There are no well-controlled studies that have been done in pregnant women. Methylergonovine should be used during pregnancy only if the possible benefit outweighs the possible risk to the unborn baby.
No studies have been done in animals, and no well-controlled studies have been done in pregnant women. Methylergonovine should be given to a pregnant woman only if clearly needed.
Take methylergometrine exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.
The Methylergometrine dose your doctor recommends will be based on the following (use any or all that apply):
- the condition being treated
- other medical conditions you have
- other medications you are taking
- how you respond to this medication
- your weight
- your height
- your age
- your gender
Methylergometrine is available in the following doses:
- Methylergonovine 0.2 Mg Oral Tablet
- Methylergonovine 0.2 Mg/ml Injectable Solution
Forms of Medication
Methylergometrine is available in the following forms:
- Injectable Solution
- Oral Tablet